Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Code:
NCT05170399
Conditions
Lymphoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Fluzone
Shingrix
Flucelvax
Afluria
PREVNAR 13
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by National Heart, Lung, and Blood Institute (NHLBI) on 2025-03-25.